ISB News

Resonance: Celebrating Professor Ilya Shmulevich’s Life and Scientific Contributions

ISB hosted a full-day symposium – titled Resonance – celebrating the life and scientific contributions of Professor Ilya Shmulevich, who passed away in April 2024 from complications of acute myeloid leukemia. 

The symposium featured speakers whose research resonates with and has been profoundly influenced by Dr. Shmulevich’s work. Session topics included digital health, modeling and theory, and cancer genomics, reflecting the broad impact of his scientific legacy.

The day-long event was recorded. You can view the entire Resonance playlist on YouTube, or watch the videos below.

Dr. Jim Heath delivers opening remarks. 

Dr. Lee Hood: “My Interactions with Ilya and the Human Phenome Initiative”

Dr. Sui Huang: “From Boolean Networks to Digital Twins”

Dr. Reinhard Laubenbacher: “Ilya Shmulevich and His Work on Cancer Digital Twins”

Dr. Olli Yi-Harja: “Modeling with Ilya”

Dr. Stuart Kauffman

Morning session discussion

Dr. Theo Knijnenburg: Session on Cancer Genomics

Dr. Wei Zhang: “Ilya Shmulevich’s Impact: Bridging Cancer Genomics and Systems Science”

Dr. Nyasha Chambwe: “The Enduring Influence of Ilya Shmulevich in Cancer Genomics”

Dr. Peter Laird

Afternoon session and closing remarks

View the entire Resonance playlist on YouTube.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.